Stocks

Company news

| Updated on January 11, 2018 Published on May 11, 2017

Indoco Remedies has informed the exchanges that it has received approval from the UK regulatory body UK Medicines and Healthcare products Regulatory Agency, for its solid dosages manufacturing facility at Goa (Plant I). This approval follows the inspection conducted in December 2016. The company is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients. After surging to a high of ₹249.80 on the NSE in earlier trades in the day, shares of Indoco Remedies closed ₹4.95 lower vis-à-vis the previous day’s close at ₹225 on the NSE.

Gravita India has informed the exchanges that its engineering and lead recycling turnkey solutions arm has received orders worth ₹15 crore from Metal Lead Factory for Metals Casting and Quiwan Group from the Middle East. The orders will be executed by the end of December 2017. The company further said the order is from independent international parties and the promoters or promoter group companies have no interest in the entities providing the order. Shares of Gravita hit a year high of ₹74.95 before closing at ₹72.75, a gain of 1.6 per cent, on the NSE.

Ujaas Energy has been awarded an additional allocation order of 2,500Kwp grid connected SPV power plants under the ‘Rooftop Solar Power Generation Scheme 2015-16’ in Rajasthan. Also, of all the other bidders in the first allotment, UJAAS is the only company to be awarded an additional allocation order. Shares of Ujaas Energy slipped 1.22 per cent at ₹36.30 on the NSE.

Published on May 11, 2017

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.